CHLAMYDIAL INFECTIONS (INTRACELLULAR INFECTION) IN THE DEVELOPMENT OF BRONCHITIS (review)
Keywords:
infection, intracellular, bronchitisAbstract
Respiratory diseases dominate in the pathology of childhood, having a significant impact on child mortality and causing the formation of persistent deviations in the health status of children. The high prevalence of acute respiratory infections among children is an important social problem, the solution of which is one of the main tasks of public health in pediatrics. It is known that children with frequent acute respiratory infections are at risk of developing acute bronchitis, bronchiolitis, the formation of recurrent bronchitis, including obstructive forms, and chronic bronchopulmonary pathology.
References
Soloveva N.A., Ilenkova N.A., Smirnova S.V. Bronxoobstruktivniy sindrom v pediatrii. Pediatriya. Ukraina 2014; 46.
Todoriko L.D., Semyaniv I.O. Osoblivostі bronxoobstruktivnogo sindromu u Xvorix natuberkulozlegenіv. Todorіko L.D., Sem'yanіv I.O. Klіnіchnaіmunologіya. Alergologіya. Іnfektologіya. 2012; 1-2 (50-51):48-51.
Xamraev X.T., Ataeva M.S., Ametov E.T., Kuldoshev S.F., Xusainova Sh.K., Karimova D.V. Bronxoobstruktivniy sindrom u detey rannego vozrasta i ego kliniko-immunologicheskie aspekti. XLIX international correspondence scientific-practical conference "European recearch: inovation in science, education andtechnology".2019. 64-66.
Shavazi N.M., Lim M.V., Tambriazov M.F. Genealogicheskie aspekti ostrogo obstruktivnogo bronxita u detey. Vestnik vracha. 2017; 1:39-42.
Shavazi N.M., Rustamov M.R., Lim M.V. E: I INDEX -metod ob'ektivnoy otsenki bronxoobstruktivnogo sindroma u detey. Academy. 2019; 10 (49):45-50.
Shavazi N.M., Lim M.V., Isaeva L.I., Shuleshko M.A., Allanazarov A.A. Bronxoobstruktivniy sindrom u detey: faktori formirovaniya, prichini. Vestnik vracha. 2016; 3:40-44.
Kudratova, Z., Muhamadieva L. Pathogenetic features of bronchobstructive syndrome in children. Scientific research results in pandemic conditions (COVID-19). Proceedings of International Multidisciplinary Conference. June, 2020. Part-5:24-27.
Mercedes R., Irvin ChG. Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases. International Journal of Biological Sciences. 2012; 8:1281-1290.
Oft M. IL-10: master switch from tumor-promoting inflammation toantitumor immunity. Cancer Immunol Res. 2014; 2(3): 194-199.
Quinn SR, O'Neill LA. The role of microRNAs in the control and mechanism of action of IL.Cur Top Microbiol Immunology 2014: 380:145-155.
Richter J, Panayiotou C, Tryfonos C, Koptides D, Koliou M, Kalogirou N, et al. Etiology of acute respiratory tract infections in hospitalized children in Сyprus. 2016; 11:147-152
Stupnizka GYa, Fedіv OI, Pritulyak OV, Yuchimchuk VV. Chronіchne obstruktivne zachvoryuvannya legen': dvіstoroni odnї medalі. Ukraїns'kiy terapevtichniy zhurnal. 2013; 4: 85-92.
Shinwan Kany, Jan Tilmann Vollrath, Borna Relja. Cytokines in Inflammatory Disease. International Journal of Molecular Sciences. 2019; 20:106-108.
Wuppermann FN, Hegemann JH, Jantos CA. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. Journal Infection Diseases. 2001; 184:181-187.
Zhao Y, Xiong Z, Lechner EJ, Klenotic PA, Hamburg BJ, Hulver M, Khare A, Oriss T, Mangalmurti N, Chan Y, et al. Thrombospondin-1 triggersmacrophage IL-10 production and promotes resolution of experimentallung injury. Mucosal Immunol. 2014; 7(2): 440-460.
Chen CJ, Kono H, Golenbock D, Reed G, Akira G, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13: 851-856.
Dobrodeeva L. K., the immune system of people living in the North in zones of varying degrees of extremeness / L. K. Dobrodeeva, L. V. Senkov, E. V. Chibisova etc. //Immunologiya, 2004. -Vol. 25, No. 5.: 299-301.
Makarova V. I., Makarov A. I. the Role of cytokines in the inflammatory response // human Ecology 2008 :31-35.
Spiders V. S. the Role of macrophages in the pathogenesis of limited inflammation / V. S. Spiders, S. A. Daabul, N. Yu. Belyaeva // Archive of pathology. -2005. -Vol. 67, No. 4: 311-316.
Levit D. A. Acute catabolic state in systemic inflammatory response syndrome of various etiologies. Attempt of clinical analysis / D. A. Levit, I. N. Leiderman // Bulletin of intensive
therapy. -2006. -No. 2.: 9-14.
Zheleznikova G. F. Infection and immunity: strategies of both sides / G. F. zheleznikova / / Medical immunology. -2006. -Vol. 8, No. 5-6.: 597-614.
Levit D. A. Features of acute phase response and cytokinemia in systemic inflammatory response of infectious and non-infectious Genesis / D. A. Levit, I. N. Leiderman, E. Yu. Gusev, A. L. Levit // Infections in surgery. -2007. -No. 1.: 33-37.
Sh. I. Navruzova. Cytokine status and humoral immunity depending on the recurrence rate of obstructive bronchitis in children / Sh. I. Navruzova, D. N. Achilova // American Journal of Medicine and Medical Sciences 2020, 10(1).: 66-71.
Z. Kudratova, L. Muhamadieva. Pathogenetic features of bronch-obstructive syndrome in children. Scientific research results in pandemic conditions (COVID-19) Proceedings of International Multidisciplinary Conference. Part-5. P-24-27, June, 2020
Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH, Hardy RD. Diagnostic utility and clinical significance of naso-and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infections in children with community-acquired pneumonia. J. Clin. Microbiol. 2004; 42: 3339-3341.
Kudratova Z. E., Mukhamadieva L. A., Kuvandikov G. B. Features of the etiopathogenesis of obstructive bronchitis and laryngotracheitis caused by atypical microflora. Journal of achievements in science and education, 2020-No. 14 (68). p.-27-28.
